Xilio Therapeutics Inc. (XLO)
NASDAQ: XLO
· Real-Time Price · USD
0.70
-0.00 (-0.38%)
At close: Aug 15, 2025, 3:59 PM
0.71
0.58%
After-hours: Aug 15, 2025, 04:04 PM EDT
Xilio Therapeutics Fail-to-Deliver
Total FTD Shares
1.31K
Below Average
FTD / Avg. Volume
0.23%
Low Impact
1-Year Change
-43.5%
Negative Trend
FTD Chart
As of Jul 14, 2025,
Xilio Therapeutics Inc. has
1,315
shares failed to deliver, representing 0.23%
of the average daily volume of
575,200
shares. Over the past year, the monthly average FTD is
53,646
shares, with the current level 98% below
the historical average, indicating
low
settlement pressure. The weighted FTD ratio below 1% suggests normal market making activity with adequate liquidity.
FTD History
Date | Price | FTD Shares | % Change |
---|---|---|---|
Jul 14, 2025 | 0.7396 | 1.31K | -91.32% |
Jun 30, 2025 | 0.6799 | 15.15K | +669.14% |
May 29, 2025 | 0.9639 | 1.97K | -23.85% |
Apr 30, 2025 | 0.7657 | 2.59K | -32.37% |
Mar 31, 2025 | 0.7244 | 3.83K | -85.82% |
Feb 27, 2025 | 0.8921 | 26.98K | +24653.21% |
Jan 17, 2025 | 1.14 | 109 | -99.48% |
Dec 26, 2024 | 0.975 | 20.93K | +164.26% |
Nov 20, 2024 | 0.9412 | 7.92K | -85.01% |
Oct 31, 2024 | 1.27 | 52.84K | +2194.27% |
Sep 30, 2024 | 0.7877 | 2.3K | +40.51% |
Aug 23, 2024 | 0.9023 | 1.64K | -45.60% |
Jul 23, 2024 | 1.01 | 3.01K | +317.89% |
Jun 28, 2024 | 0.9475 | 721 | -82.85% |
May 30, 2024 | 0.9301 | 4.2K | -91.17% |
Apr 30, 2024 | 1.04 | 47.6K | +509.58% |
Mar 28, 2024 | 1.08 | 7.81K | +190.62% |
Feb 23, 2024 | 0.5821 | 2.69K | +15.37% |
Jan 16, 2024 | 0.6552 | 2.33K | +6750.00% |
Dec 19, 2023 | 0.601 | 34 | -97.34% |
Nov 27, 2023 | 1.11 | 1.28K | +535.32% |
Oct 30, 2023 | 2.1 | 201 | -50.12% |
Sep 26, 2023 | 2.22 | 403 | +5657.14% |
Aug 11, 2023 | 2.8 | 7 | -97.97% |
Jul 26, 2023 | 2.82 | 345 | -47.41% |
Jun 26, 2023 | 2.7 | 656 | -64.15% |
May 26, 2023 | 3.06 | 1.83K | +159.94% |
Apr 28, 2023 | 3.3 | 704 | +282.61% |
Mar 29, 2023 | 3.01 | 184 | -96.13% |
Feb 23, 2023 | 3.64 | 4.76K | +1605.73% |
Jan 31, 2023 | 3.65 | 279 | n/a |